This world famous daily In the special report, Mr. Sakif Shamim, visionary managing director of LabAid Cancer Hospital and Super Specialty Center and Deputy Managing Director of LabAid Group, has undoubtedly opened a new horizon in establishing Bangladesh as a budding center in the global healthcare map.
USA Today is one of the largest and most widely circulated daily newspapers in the United States, with its dynamic design, short, clear reports and the inclusion of popular culture stories, which has influenced the style of many newspapers around the world, which has reached millions of readers around the world and highlighted the activities of LabAid in Bangladesh and the health technology and medical capabilities of Bangladesh have been internationally recognized.
Sakif Shamim is currently leading the LabAid Group, which started its journey in the hands of his father in 1984. It is now a sixth specialized hospital, 45 diagnostic centers, a medical college, pharmaceuticals, real estate, education. The country has become the largest healthcare group with more than 12,000 employees, including the LabAid Cancer Hospital and Super Specialty Center under his leadership, currently being considered one of the top and the best hospitals in the country, which is providing from diagnosis to integrated cancer care.
Sakif Shamim's leadership has revolutionized healthcare, he founded LifePlus Bangladesh, one of the country's largest healthtech companies with more than three lakh active users.
Besides, he launched a generic AI platform called Labaid GPT, which is aimed at providing secondary facilities for doctors and patients and is powered by many years of data reserved data of Labaid. In his visionary initiative, Labaid Group VirtueCare AI (VirtueCare AI) has also started using Augmented Restability (Ar) and Virtual Resources (VR) technology, aimed at developing technology in South Asia, Africa and the likelihood of the region.
LabAid Group's expansion strategy is far-reaching; they have planned to build a 750-bed super-specialty hospital in Dhaka at a 250 million dollars (approximately 2000 crores) and have planned to set up 30 cancer centers in the country in the next 5 to 7 years. In addition to LabAid Bangladesh, LabAid is preparing to become public in Singapore and Hong Kong in addition to its own efforts to become public in Singapore and Hong Kong.
"LabAid is not just a healthcare provider—it's a platform for transformation," Sakif Shamim said, "The ultimate goal of Bangladesh is to bring about radical changes in the medical sector in Bangladesh."
He believes that Bangladeshis will no longer have to go abroad for treatment through proper infrastructure and partnership, but Bangladesh can attract patients from neighboring countries. His ambitious plan is to convert LabAid Group into $10 billion corporations in the next five years, through which world-class healthcare can be delivered to about 7-8 million people in three to four years. According to Sakif Shamim, world-class healthcare is not a luxury, but every human being.
